Psychopharmacology

, Volume 58, Issue 2, pp 207–211 | Cite as

Tardive dyskinesia: Age and sex differences in hospitalized schizophrenics

  • James M. Smith
  • William T. Oswald
  • L. Thomas Kucharski
  • Laura J. Waterman
Article

Abstract

An examination of the severity of tardive dyskinesia in psychiatric inpatients using the Abnormal Involuntary Movement Scale (AIMS) indicates differing trends with age for each sex. Females show a significant linear increase with age, while males display a significant curvilinear relationship. Reliable differences between males and females are found only for the 70–79 and ≥80 year age groups. The differences between the sexes cannot be accounted for by differences in length of current hospitalization or by current level of neuroleptic medication. Possible reasons for the results are discussed.

Key words

Tardive dyskinesia Movement disorders Neuroleptics Extrapyramidal system Side effects 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American College of Neuropsychopharmacology: Neurological syndromes associated with antipsychotic drug use. Arch. Gen. Psychiatry 28, 463–466 (1973)Google Scholar
  2. Brandon, S., McClelland, H. A., Protheroe, C.: A study of facial dyskinesia in a mental hospital population. Br. J. Psychiatry 118, 171–184 (1971)Google Scholar
  3. Crane, G. E.: Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs. Agressologie 9, 209–216 (1968)Google Scholar
  4. Crane, G. E., Paulson, G.: Involuntary movements in a sample of chronic mental patients and their relation to the treatment with neuroleptics. Int. J. Neuropsychiatry 3, 286–291 (1967)Google Scholar
  5. Dincmen, K.: Chronic psychotic choreo-athetosis. Dis. Nerv. Syst. 27, 399–402 (1966)Google Scholar
  6. Fann, W. E., Davis, J. M., Janowsky, D. S.: The prevalence of tardive dyskinesias in mental hospital patients. Dis. Nerv. Syst. 33, 182–186 (1972)Google Scholar
  7. Fracchia, J., Sheppard, C., Merlis, S.: Combination medications in psychiatric treatment: patterns in a group of elderly hospital patients. J. Am. Geriatr. Soc. 19, 301–307 (1971)Google Scholar
  8. Guy, W.: ECDEU assessment manual for psychopharmacology-revised 1976. Washington, D.C.: DHEW 1976Google Scholar
  9. Kazamatsuri, H., Chien, C.-P., Cole, J. O.: Therapeutic approaches to tardive dyskinesia. Arch. Gen. Psychiatry 27, 491–499 (1972)Google Scholar
  10. Kennedy, P. F., Hershon, H. I., McGuire, R. J.: Extrapyramidal disorders after prolonged phenothiazine therapy. Br. J. Psychiatry 118, 509–518 (1971)Google Scholar
  11. Klawans, H. L., Jr.: The pharmacology of tardive dyskinesias. Am. J. Psychiatry 130, 82–86 (1973)Google Scholar
  12. Laska, E., Varga, E., Wanderling, J., Simpson, G., Logemann, G. W., Shah, B. K.: Patterns of psychotropic drug use for schizophrenia. Dis. Nerv. Syst. 34, 294–305 (1973)Google Scholar
  13. Mettler, F. A., Crandell, A.: Neurologic disorders in psychiatric institutions. J. Nerv. Ment. Dis. 128, 148–159 (1959)Google Scholar
  14. Prien, R. F., Haber, P. A., Caffey, E. M.: The use of psychoactive drugs in elderly patients with psychiatric disorders: survey conducted in twelve veterans administration hospitals. J. Am. Geriatr. Soc. 23, 104–112 (1975)Google Scholar
  15. Samorajski, T.: Central neurotransmitter substances and aging: a review. J. Am. Geriatr. Soc. 25, 337–348 (1977)Google Scholar
  16. Sheppard, C., Collins, L., Fiorentino, D., Fracchia, J., Merlis, S.: Polypharmacy in psychiatric treatment: incidence at a state hospital. Curr. Ther. Res. 11, 765–774 (1969)Google Scholar
  17. Siede, H., Müller, H. F.: Choreiform movements as side effects of phenothiazine medication in geriatric patients. J. Am. Geriatr. Soc. 15, 517–522 (1967)Google Scholar
  18. Turunen, S., Achté, K. A.: The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy. Psychiatr. Q. 41, 268–279 (1967)Google Scholar
  19. Winer, B. J.: Statistical principles in experimental design. New York: McGraw-Hill 1962Google Scholar
  20. Wyatt, R. J.: Biochemistry and schizophrenia (part IV). The neuroleptics-their mechanism of action: a review of the biochemical literature. Psychopharmacol. Bull. 12, 5–50 (1976)Google Scholar

Copyright information

© Springer-Verlag 1978

Authors and Affiliations

  • James M. Smith
    • 1
  • William T. Oswald
    • 1
  • L. Thomas Kucharski
    • 1
  • Laura J. Waterman
    • 1
  1. 1.Office of Clinical ResearchHarlem Valley Psychiatric CenterWingdaleUSA

Personalised recommendations